Gastrointestinal
Health

Food-Related Connection

Mapping delayed food-antibody reactivity
that may help contextualize complex
gastrointestinal presentations.

Gastrointestinal symptoms are frequently multifactorial, and patients may continue consuming foods that contribute to their symptom burden without recognizing a diet connection, since IgG-mediated reactions can be delayed by hours or days after ingestion[1,2].

The IgG Food MAP with Candida + Yeast is a dried blood spot (or serum) profile measuring total IgG antibody reactivity to specific foods, herbs, and spices, along with Candida albicans and Saccharomyces cerevisiae reactivity[1–7].

When Might Providers Consider the IgG Food MAP

Neurologic & Mental Health – Food-Related Connection1


GI Upset with Unclear Dietary Triggers:

Recurrent bloating, gas, or diarrhea where a specific food connection is not obvious to the patient due to delayed symptom onset.[1,2]


Suspected Non-Celiac Gluten/Wheat Sensitivity: 

GI or extra-intestinal symptoms associated with gluten ingestion in patients who have ruled out celiac disease via standard serology.[3,4]


Irritable Bowel Syndrome (IBS):

 IBS presentations, particularly where structural workup is unremarkable, that may benefit from a food-antibody-guided elimination approach.[1,2,7]


Inflammatory Bowel Disease (Crohn’s & Ulcerative Colitis):

Complex or relapsing presentations where dietary triggers may be an adjunctive consideration alongside conventional management.[6]


Candida & Fungal Overgrowth Concerns:

GI complaints alongside signs suggestive of Candida overgrowth (e.g., bloating, fatigue, oral thrush, skin/nail changes) where fungal-driven barrier disruption may be contributing to secondary food reactivity.[6] 


GI Symptoms with Overlapping Systemic Features: 

GI complaints co-occurring with headaches/migraines, skin rash or eczema, fatigue, or behavioral/mood changes, suggestive of broader food-antigen sensitivity.[2,5]

Analyte ClassWhat It ReflectsGI Relevance
Total IgG Food Antibodies (192 Analytes)IgG-mediated antibody reactivity to a broad panel of foods, herbs, and spices common to Western, Asian, and Mediterranean diets.May help identify delayed-onset dietary triggers relevant to chronic or recurrent GI symptom patterns not explained by IgE-mediated (immediate) food allergy testing[2,4].
Candida albicans IgG ReactivityAntibody response associated with Candida overgrowth in the GI tract.May provide context for fungal dysbiosis patterns that have been proposed to contribute to increased intestinal permeability and secondary food-antigen reactivity[6].
Saccharomyces cerevisiae (Yeast) IgG ReactivityAntibody response associated with yeast exposure and overgrowth patterns.May offer additional context for microbial/fungal contributors to GI symptom burden alongside Candida markers[6].
Gluten-Related Analytes (Gliadin, Wheat Gluten, Whole Wheat)IgG antibody reactivity to gluten-containing proteins, distinct from celiac-specific serology.May help contextualize non-celiac gluten/wheat sensitivity presentations in patients who do not meet celiac diagnostic criteria[3,4].
Dairy, Egg & Common Allergenic Food GroupsIgG reactivity to frequently consumed proteins (e.g., casein, whey, egg white, egg yolk) implicated in delayed food-reactivity patterns.May support elimination/rotation diet planning in patients with chronic bloating, altered bowel habits, or overlapping systemic complaints[1,2].

Structures Dietary Hypothesis-Testing

Results can guide a supervised elimination and reintroduction diet protocol when a food-symptom relationship is suspected but unclear, offering a more organized approach that trial-and-error exclusion[1,2].

Contextualizes Multisystem Symptom Patterns

In patients with overlapping GI and concurrent systemic symptoms – including neurological, skin, and mood complains—IgG reactivity data may help contextualize the broader clinical picture and inform integrative dietary and lifestyle interventions[,2,5].

Supports Patient Engagement & Adherence

Providing patients with individualized food-reactivity data can increase motivation to adhere to dietary modification and elimination protocols when symptom attribution may have been ambiguous previously.

How to Order

Neurologic & Mental Health – Food-Related Connection1

To order the IgG Food MAP with Candida + Yeast, register for a portal account. Specimen collection kits and requisition forms are available through your account portal. For clinical support or interpretation questions, contact our clinical education team.

This webpage is intended for licensed healthcare professionals and is for informational and educational purposes only. The test results are not intended to diagnose, treat, cure, or prevent disease. All clinical interpretation should be done by a qualified healthcare professional in the context of the individual patient. Statements regarding associations between health symptoms and conditions do not constitute diagnostic claims.

References

  1. Atkinson W, Sheldon TA, Shaath N, Whorwell PJ. Food elimination based on IgG antibodies in irritable bowel syndrome: a randomised controlled trial. Gut. 2004;53(10):1459-1464. doi:10.1136/gut.2003.037697.
  2. Drisko J, Bischoff B, Hall M, McCallum R. Treating irritable bowel syndrome with a food elimination diet followed by food challenge and probiotics. J Am Coll Nutr. 2006;25(6):514-522. doi:10.1080/07315724.2006.10719567
  3. Maimaris S, Scarcella C, Memoli GA, Crisciotti C, Schiepatti A, Biagi F. Non-Coeliac Wheat Sensitivity: Symptoms in Search of a Mechanism, or a Distinct Well-Defined Clinical Entity? A Narrative Review. Int J Mol Sci. 2025;26(22):11174. Published 2025 Nov 19. doi:10.3390/ijms262211174
  4. Uhde M, Caio G, De Giorgio R, Green PH, Volta U, Alaedini A. Subclass Profile of IgG Antibody Response to Gluten Differentiates Nonceliac Gluten Sensitivity From Celiac Disease. Gastroenterology. 2020;159(5):1965-1967.e2. doi:10.1053/j.gastro.2020.07.032
  5. Alpay K, Ertas M, Orhan EK, Ustay DK, Lieners C, Baykan B. Diet restriction in migraine, based on IgG against foods: a clinical double-blind, randomised, cross-over trial. Cephalalgia. 2010;30(7):829-837. doi:10.1177/0333102410361404
  6. Michielan A, D’Incà R. Intestinal Permeability in Inflammatory Bowel Disease: Pathogenesis, Clinical Evaluation, and Therapy of Leaky Gut. Mediators Inflamm. 2015;2015:628157. doi:10.1155/2015/628157
  7. Napolitano M, Fasulo E, Ungaro F, et al. Gut Dysbiosis in Irritable Bowel Syndrome: A Narrative Review on Correlation with Disease Subtypes and Novel Therapeutic Implications. Microorganisms. 2023;11(10):2369. Published 2023 Sep 22. doi:10.3390/microorganisms11102369


All trademarks are owned by the company and its affiliates. ©2026 Mosaic Diagnostics. All Rights Reserved. MDX_GI_IGG_10-2026.v1

Not sure which testing path fits your patient?

Our clinical team helps you choose the right panel and interpret results with confidence.